NLRP3 and metabolic dysfunction-associated steatotic liver disease: As shown in Supplementary Figure 3, we may speculate that mechanism underlying its effects involves antioxidative stress and regulation of AMPK-dependent TXNIP/NLRP3 signaling pathway, thus representing a potentially powerful target for NAFLD pharmacological purposes.